Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 100,000 shares at $43.34 ($4.3M) on 2018-07-11, disclosed to the SEC on 2018-07-13.
Open-market sale of $4.3M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.34 | 3,861 | $167K | 3.9% |
| 2 | $43.34 | 3,861 | $167K | 3.9% |
| 3 | $43.34 | 46,139 | $2.0M | 46.1% |
| 4 | $43.34 | 46,139 | $2.0M | 46.1% |
| Total | $43.34 avg | 100,000 | $4.3M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |